Copper ions regulate cytotoxicity of disulfiram to myeloid leukemia cells

International Journal of Molecular Medicine

Volumn 24, Issue 5, 2009, Pages 661-670

  Navrátilová, Jarmila ^a   Jungová, Pavla ^a   Vanhara, Petr ^a   Preisler, Jan ^a   Kanicky, Viktor ^a   Smarda, Jan ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cell density; Copper; Disulfiram; Inoculum effect; Myeloid leukemia; SALD ICP MS

Indexed keywords

COPPER ION; DISULFIRAM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOACCUMULATION; CANCER INHIBITION; CELL CYCLE ARREST; CELL DENSITY; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN U937; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PRIORITY JOURNAL; REGULATORY MECHANISM;

ACETYLCYSTEINE; CELL COUNT; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COPPER; CULTURE MEDIA, CONDITIONED; DISULFIRAM; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; INTRACELLULAR SPACE; IONS; LEUKEMIA, MYELOID;

EID: 70350749141     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000277     Document Type: Article

References (29)

1. Friedmann AM and Weinstein HJ: The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist 5: 321-328, 2000.
2. Matthews JP, Bishop JF, Young GA, et al: Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia. Br J Haematol 113: 727-736, 2001.
3. Masquelier M and Vitols S: Drastic effect of cell density on the cytotoxicity of daunorubucin and cytosine arabinoside. Biochem Pharmacol 67: 1639-1646, 2004.
4. Takemura Y, Kobayashi H, Miyachi H, Hayashi K, Sekiguchi S and Ohnuma T: The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro. Cancer Chemother Pharmacol 27: 417-422, 1991.
5. Kobayashi H, Takemure Y, Holland JS and Ohnuma T: Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells. Biochem Pharm 55: 1229-1234, 1998.
6. Brandt S, Heller H, Schuster KD and Grote J: Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity. Liver Int 24: 46-54, 2004.
7. Jang SH, Wientjes MG and Au JL: Determinants of paclitaxel uptake, accumulation and retention in solid tumors. Invest New Drugs 19: 113-123, 2001.
8. Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, et al: Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res 61: 6281-6289, 2001.
9. Valkov NI, Gump JL, Engel R and Sullivan DM: Cell density-dependent VP-16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIalpha from the nucleus to the cytoplasm. Br J Haematol 108: 331-345, 2000.
10. Chick J: Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 20: 427-435, 1999.
11. Wickstrom M, Danielsson K, Rickardson L, Gullbo J, Nygren P, Isaksson A, Larsson R and Lovborg H: Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. Biochem Pharmacol 73: 25-33, 2007.
12. Brar SS, Grigg C, Wilson KS, et al: Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Mol Cancer Ther 3: 1049-1060, 2004.
13. Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB and Meyskens FL Jr: Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther 1: 197-204, 2002.
14. Chen D, Cui QC, Yang H and Dou QP: Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 66: 10425-10433, 2006.
15. Burkitt MJ, Bishop HS, Milne L, Tsang SY, Provan GJ, Nobel CS, Orrenius S and Slater AF: Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch Biochem Biophys 353: 73-84, 1998.
16. Cen D, Brayton D, Shahandeh B, Meyskens FL Jr and Farmer PJ: Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem 47: 6914-6920, 2004.
17. Chen SH, Liu SH, Liang YC, Lin JK and Lin-Shiau SY: Death signaling pathway induced by pyrrolidine dithiocarbamate-Cu(2+) complex in the cultured rat cortical astrocytes. Glia 31: 249-261, 2000.
18. Chen D, Peng F, Cui QC, Daniel KG, Orlu S, Liu J and Dou QP: Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Front Biosci 10: 2932-2939, 2005.
19. 2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. Chem Biol Interact 171: 26-36, 2008.
20. Erl W, Weber C and Hansson GK: Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(2+) and Zn(2+). Am J Physiol Cell Physiol 278: C1116-C1125, 2000.
21. Watanabe T, Yoshizumi M, Akishita M, et al: Induction of nuclear orphan receptor NGFI-B gene and apoptosis in rat vascular smooth muscle cells treated with pyrrolidine-dithiocarbamate. Arterioscler Thromb Vasc Biol 21: 1738-1744, 2001.
22. Vindelov LL: Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and staining of nuclei. Virchows Arch B Cell Pathol 24: 227-242, 1977.
23. Pes O, Jungova P, Vyhnanek R, Vaculovic T, Kanicky V and Preisler J: Off-line coupling of capillary electrophoresis to substrate-assisted laser desorption inductively coupled plasma mass spectrometry. Anal Chem 80: 8725-8732, 2008.
24. Slapak CA, Lecerf JM, Daniel JC and Levy SB: Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts. J Biol Chem 267: 10638-10644, 1992.
25. Ohnuma T, Arkin H and Holland JF: Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect). Br J Cancer 54: 415-421, 1986.
26. Sauna ZE, Shukla S and Ambudkar SV: Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections. Mol Biosyst 1: 127-134, 2005.
27. Schwarze CP, Neu S, Beck J, Mavridou K, Ranke MB and Binder G: Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM. Horm Res 52: 192-199, 1999.
28. Akca T, Canbaz H, Tataroglu C, et al: The effect of N-acetyl-cysteine on pulmonary lipid peroxidation and tissue damage. J Surg Res 129: 38-45, 2005.
29. Venelinov TI, Davies IM and Beattie JH: Dialysis-Chelex method for determination of exchangeable copper in human plasma. Anal Bioanal Chem 379: 777-780, 2004.